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A B S T R A C T
Background
Delirium is a common and distressing mental disorder. It is often caused by a combination of stressor events in susceptible people,
particularly older people living with frailty and dementia. Adults living in institutional long-term care (LTC) are at particularly high
risk of delirium. An episode of delirium increases risks of admission to hospital, development or worsening of dementia and death.
Multicomponent interventions can reduce the incidence of delirium by a third in the hospital setting. However, it is currently unclear
whether interventions to prevent delirium in LTC are effective. This is an update of a Cochrane Review first published in 2014.
Objectives
To assess the effectiveness of interventions for preventing delirium in older people in institutional long-term care settings.
Search methods
We searched ALOIS (www.medicine.ox.ac.uk/alois), the Cochrane Dementia and Cognitive Improvement Group ( CDCIG) ’s Spe-
cialised Register of dementia trials ( dementia.cochrane.org/our-trials-register), to 27 February 2019. The search was sufficiently sen-
sitive to identify all studies relating to delirium. We ran additional separate searches in the Cochrane Central Register of Controlled
Trials (CENTRAL), major healthcare databases, trial registers and grey literature sources to ensure that the search was comprehensive.
Selection criteria
We included randomised controlled trials (RCTs) and cluster-randomised controlled trials (cluster-RCTs) of single andmulticomponent,
non-pharmacological and pharmacological interventions for preventing delirium in older people (aged 65 years and over) in permanent
LTC residence.
Data collection and analysis
We used standard methodological procedures expected by Cochrane. Primary outcomes were prevalence, incidence and severity of
delirium; and mortality. Secondary outcomes included falls, hospital admissions and other adverse events; cognitive function; new
diagnoses of dementia; activities of daily living; quality of life; and cost-related outcomes. We used risk ratios (RRs) as measures of
treatment effect for dichotomous outcomes, hazard ratios (HR) for time-to-event outcomes and mean difference (MD) for continuous
outcomes. For each outcome, we assessed the overall certainty of the evidence using GRADE methods.
1Interventions for preventing delirium in older people in institutional long-term care (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
We included three trials with 3851 participants. All three were cluster-RCTs. Two of the trials were of complex, single-component, non-
pharmacological interventions and one trial was a feasibility trial of a complex, multicomponent, non-pharmacological intervention.
Risk of bias ratings were mixed across the three trials. Due to the heterogeneous nature of the interventions, we did not combine the
results statistically, but produced a narrative summary.
It was not possible to determine the effect of a hydration-based intervention on delirium incidence (RR 0.85, 95% confidence interval
(CI) 0.18 to 4.00; 1 study, 98 participants; very low-certainty evidence downgraded for risk of bias and very serious imprecision). This
study did not assess delirium prevalence, severity or mortality.
The introduction of a computerised system to identify medications that may contribute to delirium risk and trigger a medication
review was probably associated with a reduction in delirium incidence (12-month HR 0.42, CI 0.34 to 0.51; 1 study, 7311 participant-
months; moderate-certainty evidence downgraded for risk of bias) but probably had little or no effect on mortality (HR 0.88, CI 0.66 to
1.17; 1 study, 9412 participant-months; moderate-certainty evidence downgraded for imprecision), hospital admissions (HR 0.89, CI
0.72 to 1.10; 1 study, 7599 participant-months; moderate-certainty evidence downgraded for imprecision) or falls (HR 1.03, CI 0.92
to 1.15; 1 study, 2275 participant-months; low-certainty evidence downgraded for imprecision and risk of bias). Delirium prevalence
and severity were not assessed.
In the enhanced educational intervention study, aimed at changing practice to address key delirium risk factors, it was not possible to
determine the effect of the intervention on delirium incidence (RR 0.62, 95% CI 0.16 to 2.39; 1 study, 137 resident months; very
low-certainty evidence downgraded for risk of bias and serious imprecision) or delirium prevalence (RR 0.57, 95% CI 0.15 to 2.19; 1
study, 160 participants; very low-certainty evidence downgraded for risk of bias and serious imprecision). There was probably little or
no effect on mortality (RR 0.82, CI 0.50 to 1.34; 1 study, 215 participants; moderate-certainty evidence downgraded for imprecision).
The intervention was probably associated with a reduction in hospital admissions (RR 0.67, CI 0.57 to 0.79; 1 study, 494 participants;
moderate-certainty evidence downgraded due to indirectness).
Authors’ conclusions
Our review identified limited evidence on interventions for preventing delirium in older people in LTC. A software-based intervention to
identify medications that could contribute to delirium risk and trigger a pharmacist-led medication review, probably reduces incidence
of delirium in older people in institutional LTC. This is based on one large RCT in the US and may not be practical in other countries
or settings which do not have comparable information technology services available in care homes. In the educational intervention
aimed at identifying risk factors for delirium and developing bespoke solutions within care homes, it was not possible to determine the
effect of the intervention on delirium incidence, prevalence or mortality. This evidence is based on a small feasibility trial. Our review
identified three ongoing trials of multicomponent delirium prevention interventions. We identified no trials of pharmacological agents.
Future trials of multicomponent non-pharmacological delirium prevention interventions for older people in LTC are needed to help
inform the provision of evidence-based care for this vulnerable group.
P L A I N L A N G U A G E S U M M A R Y
Interventions for preventing delirium in older people in institutional long-term care (LTC)
Review question
How effective are treatments to prevent delirium in older people living in long-term care (LTC)?
Background
LTC is the name used for residential homes, which provide personal care, supervision with medications and help with day-to-day
activities, and nursing homes, which provide 24-hour nursing care. Delirium is a common and serious illness for older people living
in LTC. Delirium is a condition that causes confusion, usually over a few hours or days. Some people with delirium become quiet and
sleepy while others become agitated and disorientated, so it can be a very distressing condition. Delirium can increase the chances of
being admitted to hospital, developing dementia and can increase the risk of death.
Importantly, studies of people in hospital have shown that it is possible to prevent around a third of cases of delirium by providing
an environment and care plan that target the main delirium risk factors, including, providing better lighting and signs to avoid
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disorientation; avoiding unnecessary use of catheters to help prevent infection; and avoiding certain medications which increase the
risk of delirium.
This review has searched for and assessed research on preventing delirium in older people living in LTC.
Study characteristics
The evidence is current to February 2019. We found three studies that included 3851 participants. Two studies took place in the US
and one study in the UK.
One study tested whether delirium could be prevented by calculating how much fluid an older person in a care home needs each day
and ensuring hydration was maintained. There were 98 people in the study, which lasted four weeks.
One study tested the effect of a computer program which searched for prescriptions of medications that might increase the chance of
developing delirium, to enable a pharmacist to adjust or stop them. There were 3538 people in the study, which lasted 12 months.
One study tested an enhanced educational intervention which included learning sessions on delirium with care home staff and group
meetings to identity targets for preventing delirium. There were 215 people in the study, which lasted 16 months.
Key findings
It was not possible to determine if the hydration intervention reduced the occurrence of delirium. This was a small study of short
duration with serious design problems.
The study of a computerised medication search programme probably reduced delirium, but there was no clear reduction in hospital
admissions, deaths or falls. A potential problem is that it might not be possible to use this computer program in different countries that
do not have similar computer systems available.
It was not possible to determine if the enhanced education intervention reduced the occurrence of delirium and there was no clear
reduction in the number of deaths. The intervention was probably associated with a reduction in hospital admissions. This is based on
findings from a small study.
Quality of the evidence
There is very low-quality evidence on the effectiveness of hydration interventions for reducing the incidence of delirium. Therefore, it
was not possible to draw firm conclusions.
There is moderate-quality evidence that a computerised medication search programme may reduce the incidence of delirium. There is
no clear evidence for reducing hospitalisations, mortality or falls.
There is very low-quality evidence of the effectiveness of an enhanced educational intervention for reducing delirium. Therefore, it was
not possible to draw firm conclusions. There is moderate-quality evidence for reducing hospital admissions.
As this review only found a small number of research studies, we recommend that further research be conducted, testing different ways
of preventing delirium for older people in LTC.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Single-component hydration intervention versus control for preventing delirium in older people in institutional long- term care
Patient or population: people at risk of delirium in inst itut ional long-term care
Settings: long-term care inst itut ions
Intervention: single-component hydrat ion intervent ion
Comparison: control
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with control Risk with single-com-
ponent hydration inter-
vention versus control
Prevalence of delirium
Not measured
- - - - - -
Incidence of delirium
NEECHAM Confusion
Scale
Follow-up: mean 4
weeks
Study population RR 0.85
(0.18 to 4.0)
98
(1 study)
⊕©©©
Very lowa,b,c
67 per 1000 57 per 1000
(12 to 268)
Severity of delirium - - - - - Not measured
Mortality - - - - - Not measured
Cognitive function - - - - - Not measured
Falls - - - - - Not measured
Hospital admissions - - - - - Not measured
* Therisk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; NEECHAM: Neelon and Champagne; RR: risk rat io.
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GRADE Working Group grades of evidence
High certainty: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate certainty: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low certainty: we are very uncertain about the est imate.
aAssessed at high risk of methodological bias for blinding, outcome data and other bias.
bOne trial only so not possible to assess for consistency.
cVery low rate of delirium events. Wide conf idence lim its indicate uncertainty; downgraded two levels for imprecision.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
Long-term care (LTC) facilities are institutions which are consid-
ered to be an individual’s ’usual place of residence’. This distin-
guishes them from other more temporary facilities, such as respite
care, intermediate care and postacute care settings. There is signif-
icant variation internationally in the terminology used to describe
LTC settings (Burton 2017). Broadly, LTC is an umbrella term
for facilities including: residential homes, which provide personal
care, supervision with medications; and some help with activities
of daily living; and nursing homes, which provide 24-hour nursing
care by staff with specialist skills in management of physical and
mental health conditions (Sanford 2015).
Delirium is a common and serious acute change in mental status,
which develops rapidly, normally over several hours to a couple of
days. It consists of a sudden confusion which is generally associ-
ated with serious illness, undergoing surgery, a change in physical
condition or receiving pharmacological treatment (Inouye 2014).
Delirium can present with hyperactive features (restlessness and
agitated behaviour) and hypoactive features (where the individual
is withdrawn and sleepy), and the clinical picture is often mixed
(Yang 2009). All subtypes are associated with increased risk of
mortality, but for people with dementia, the hypoactive form is
more serious (Yang 2009). Older adults are particularly vulnerable
to delirium, with age a significant risk factor in hospital settings
(Inouye 2014). Although a single event can precipitate delirium,
it is more common for several factors to interact and a multifacto-
rial model of delirium has been established to help illustrate how
delirium is precipitated in people at risk (Inouye 1996). Using this
model, a seemingly small insult, such as a minor infection or new
medication in people at high risk, can lead to delirium.
Delirium during hospital admission is associated with increased
risk of mortality, prolonged length of stay, functional decline and
new admission to LTC (Siddiqi 2006; Witlox 2010). Delirium
is more likely to occur in people with an established diagnosis of
dementia and is also associated with an increased likelihood of
subsequent cognitive impairment and development of dementia
(Fong 2015).
Delirium is common throughout the health and social care system
and has substantial health and socioeconomic costs (Inouye 2006;
Leslie 2008). In hospitalised people with delirium, mean costs per
day have been estimated as two and a half times those of a person
without delirium (Leslie 2008). The majority of delirium research
has focused on hospitalised people, but LTC residents are also at
high risk, with a point prevalence of delirium of around 14% in
these settings (Siddiqi 2009). Themultifactorialmodel of delirium
susceptibility has been validated in this setting (Voyer 2010), and
residents withmoderate-to-severe cognitive impairment are at par-
ticularly high risk (McCusker 2011). Level of education, malnu-
trition, antipsychotic medication use and physical restraint use are
also associated with delirium risk in LTC settings (Morichi 2018).
The development of delirium in older people in LTC is associated
with increases in risk of admission to hospital, rates of readmission
and mortality (Siddiqi 2009). Notably, delirium in LTC residents
is typically of longer duration than in hospitalised people (Cole
2012). Similarly, LTC residents with delirium have been shown to
have less frequent improvement patterns and more frequent wors-
ening patterns compared to people in acute care settings (Ciampi
2017). Although it is possible to prevent delirium in the hospital
setting by providing multicomponent delirium prevention inter-
ventions (Siddiqi 2016), it is currently unclear whether interven-
tions to prevent delirium in LTC are effective.
About 2% to 5% of older adults worldwide live in nursing home
settings (Ribbe 1997). Considering the combined effects of popu-
lation ageing, multimorbidity and dementia prevalence, it is likely
that LTC facility provision will need to expand to provide care for
increasing numbers of dependent older adults (Kingston 2018).
The environment and systems of care in LTC facilities share fea-
tures with hospitals that are likely to increase the risk of delirium.
As being older age and having cognitive impairment or dementia
are important risk factors for delirium, the high point prevalence
of delirium is likely to reflect clustering of these risk factors in
LTC.
Description of the condition
The fifth edition of the American Psychiatric Association’s Diag-
nostic and Statistical Manual of Mental Disorders (DSM-5) de-
fines delirium as a disturbance of attention (e.g. reduced ability
to focus or shift attention), awareness (e.g. reduced orientation of
surrounding environment) and cognition (e.g. memory impair-
ment, disorientation); developing rapidly and usually fluctuating
in severity over the day (APA 2013).
Key indicators in the presentation of delirium are change and
fluctuation in a range of key symptoms and behaviours including:
• cognitive function (e.g. worsened concentration, slow
responses, confusion);
• perception (e.g. visual or auditory hallucinations);
• physical function (e.g. reduced mobility, reduced
movement, restlessness, agitation, changes in appetite, sleep
disturbance);
• social behaviour (e.g. lack of co-operation, withdrawal, or
alterations in communication, mood or attitude or both (NICE
2010)).
Delirium is triggered when a susceptible person is exposed to often
multiple precipitating factors, including infection, medications,
pain and dehydration (Inouye 1998). These multiple factors are
considered to interact in a cumulative manner; the greater the
number of factors, the greater the risk of delirium. The patho-
physiology of delirium is incompletely understood, but a com-
plex interaction between acetylcholine and multiple other neuro-
transmitters, including dopamine, noradrenaline, glutamate and
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gamma-amino hydroxybutyric acid (GABA), is thought to be im-
portant (Alagiakrishnan 2004; Clegg 2011; Hshieh 2008).
Description of the intervention
This review examined the effectiveness of single- and multicom-
ponent, pharmacological and non-pharmacological interventions
for preventing delirium in older people in LTC.
Non-pharmacological interventions target the important precip-
itating factors for delirium and usually incorporate a multicom-
ponent approach to address the multiple potential factors, includ-
ing: actively looking for and treating infection; avoiding unnec-
essary urinary catheterisation; undertaking a medication review
to identify medications associated with increased risk of delirium;
assessing for pain and initiating treatment where appropriate; ad-
dressing sensory impairment by providing visual and hearing aids;
assessing and encouraging physical capabilities; and addressing
and maintaining nutrition and hydration (Boockvar 2016; NICE
2010). Multicomponent delirium prevention interventions incor-
porating such strategies have been demonstrated to be effective at
reducing delirium incidence in hospitalised adults by one third
(Siddiqi 2016). Introduction of protocols, staff education or sys-
tems redesign are methods that have been used to introduce these
interventions (Inouye 1999; Rockwood 1999). As many of the
reported risk factors for delirium are similar in both hospitalised
people and LTC residents (Siddiqi 2009), non-pharmacological
interventions that have been shown to be effective in hospitals by
targeting these risk factors may have a role in reducing the inci-
dence of delirium in LTC, with appropriate modification to ac-
count for differences in environmental factors and care processes
(McCusker 2013).
Although it is biologically plausible that pharmacological agents
could prevent delirium by acting on neurotransmitter pathways,
a small number of trials of pharmacological interventions for pre-
venting delirium in hospitalised people have demonstrated limited
effectiveness (Siddiqi 2016; Kalisvaart 2005; Tabet 2009).
How the intervention might work
Delirium is associated with various risk factors: predisposing (in-
cluding, dementia, cognitive impairment, history of delirium,
functional impairment, visual impairment, hearing impairment,
comorbidity, depression, alcohol abuse and older age) and precip-
itating factors (including, medications, use of physical restraints,
urinary catheterisation, metabolic abnormalities, surgery and in-
fections) (Inouye 2014). Non-pharmacological interventions tar-
get the multiple potential precipitating factors of delirium to re-
duce their cumulative effect. Pharmacological interventions target
neurotransmitter pathways that have been implicated in the com-
plex pathophysiology of delirium.
Why it is important to do this review
This is an update of a Cochrane Review last updated in 2014,
which examined the clinical and cost-effectiveness of pharma-
cological and non-pharmacological interventions for preventing
delirium in LTC settings. The 2014 review found limited evidence
for delirium prevention interventions due to the small number of
trials conducted in this setting. We collated evidence from ran-
domised controlled trials and cluster-randomised controlled tri-
als to provide an up-to-date evaluation. Many residents in LTC
will experience at least one episode of delirium. As the popula-
tion ages, the number of residents in LTC is on the rise. With the
numerous significant adverse outcomes associated with delirium
(including increased risk of mortality and functional decline), and
the growing economic costs that are attributable to delirium, it
is important to identify which interventions are effective in pre-
venting delirium in this setting. This evidence will help inform
the development and commissioning of evidence-based services to
improve the health and well-being of this vulnerable group. It will
also help improve knowledge about delirium in LTC, inform the
development of LTC staff education programmes and help stimu-
late future research into prevention of delirium in LTC residents.
O B J E C T I V E S
To assess the effectiveness of interventions for preventing delirium
in older people in institutional long-term care settings.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and cluster-
RCTs in this review.
Eligible trials investigated interventions for preventing delirium
in older people in LTC. It is possible that any general health in-
tervention for older people in LTC will have the effect of reduc-
ing delirium. Therefore, we only considered trials that used a val-
idated method of delirium diagnosis, such as DSM-5 and Inter-
national Classification of Diseases 10th Edition (ICD-10) (APA
2013;WHO1992), or a diagnostic tool validated against these, for
example, Confusion Assessment Method (CAM) (Inouye 1990),
and Delirium Rating Scale (DRS) (Trzepacz 1988).
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Types of participants
We included trials in which participants were residents of LTC
facilities and in which the mean participant age was 65 years or
older. In this review, LTCwas defined as an institution that was the
permanent residence of an individual, providing accommodation
together with personal or nursing care. We excluded trials taking
place in other settings, such as hospitals, palliative care settings
and settings that were not the permanent residence of study par-
ticipants (e.g. postacute care, intermediate care, continuing care).
Types of interventions
Experimental interventions were any interventions designed to
prevent delirium in LTC settings. These could have been sin-
gle- or multicomponent, pharmacological or non-pharmacologi-
cal. Comparator interventions were standard care for non-phar-
macological interventions (defined as the usual care provided on
that unit), or placebo for pharmacological interventions. These
interventions are described as complex interventions. Complex
interventions contain characteristics of different complexities, in-
cluding; number of interacting components, number and variabil-
ity of outcomes, the degree of flexibility in delivering the inter-
vention and the number of organisational levels targeted by the
intervention (Campbell 2000).
Types of outcome measures
We identified the primary, secondary and adverse outcome mea-
sures that are important both for older people in LTC and for
health and social care systems.
Primary outcomes
• Prevalence and incidence of delirium, using a validated
diagnostic method (see Types of studies).
• Severity of delirium, using a validated diagnostic method
(e.g. DRS; Trzepacz 1988)).
• Mortality.
Secondary outcomes
• Duration of delirium episode.
• Proportion of time spent with delirium (total number of
days of delirium/length of follow-up).
• Total number of delirium episodes.
• Cognitive function, using any validated continuous scale.
• New diagnosis of dementia.
• Worsening severity of dementia, using a validated diagnostic
method (e.g. Clinical Dementia Rating (CDR) scale; Morris
1993; Dementia Severity Rating Scale (DSRS); Clark 1996)).
• Quality of life.
• Direct costs of intervention.
• Health utility change and cost effectiveness of intervention.
• Activities of daily living.
• Adverse events (adverse medication outcomes, falls, new
pressure ulcers, hospital admissions).
Where data allowed, we included the following outcomes in the
’Summary of findings’ tables.
• Prevalence of delirium.
• Incidence of delirium.
• Severity of delirium.
• Mortality.
• Cognitive function, using any validated continuous scale.
• Falls.
• Hospital admissions.
Search methods for identification of studies
Electronic searches
We searched ALOIS (
www.medicine.ox.ac.uk/alois), the CDCIG’s Specialised Register
of dementia trials ( dementia.cochrane.org/our-trials-register), on
27 February 2019. The search was sufficiently sensitive to identify
all studies relating to delirium.
The Information Specialists of the CDCIG maintain ALOIS,
which contains dementia and cognitive improvement studies iden-
tified from:
• Quarterly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL) on the Cochrane Library;
• Monthly searches of a number of major healthcare
databases: MEDLINE, Embase, PsycINFO, CINAHL, and
LILACS;
• Monthly searches of a number of trial registers: meta
Register of Controlled Trials; Umin Japan Trial Register; World
Health Organization (WHO) portal (which covers
ClinicalTrials.gov; ISRCTN; Chinese Clinical trials Register;
German Clinical trials register; Iranian Registry of Clinical trials;
Netherlands National Trials Register, plus others);
• Monthly searches of grey literature sources: ISI Web of
Knowledge Conference Proceedings; Index to Theses;
Australasian Digital Theses.
To view a list of all sources searched for ALOIS (see About ALOIS
on the ALOIS website).
We ran additional separate searches in CENTRAL ( the Cochrane
Library), MEDLINE ( OvidSP), Embase ( OvidSP), PsycINFO
( OvidSP), CINAHL ( EBSCOhost), Web of Science and con-
ference proceedings ( Web of Knowledge), LILACS ( BIREME),
Clinicaltrials.gov ( www.clinicaltrials.gov), and ICTRP Search
Portal ( apps.who.int/trialsearch) to ensure that the search was as
comprehensive as possible. All search strategies and the number
of hits retrieved can be viewed in Appendix 1.
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Searching other resources
We checked the reference lists of all papers of included studies for
further potentially eligible studies.
Data collection and analysis
Selection of studies
CDCIG information specialists conducted a first assessment on
all search results. Two review authors independently examined the
titles and abstracts of citations identified by the search for eligi-
bility. We retrieved full-text copies of potentially relevant studies
and two review authors independently assessed them for inclusion,
based on the stated eligibility criteria. We settled any disagree-
ments by consensus. We collated studies represented by more than
one publication under one study reference. Review authors were
not blind to author names and affiliations when assessing studies
for inclusion.
Data extraction and management
Two review authors independently extracted data using a piloted
data extraction form, and settled any disagreements by consensus.
We created Characteristics of included studies tables and ’Sum-
mary of findings’ tables using GRADEpro (GRADEpro 2015)
and Review Manager 5 (Review Manager 2012). Review authors
were not blind to author names and affiliations of studies when
extracting data. Review authors who had been investigators on
an included study were not involved in extracting data from that
study.
We contacted study authors via email to resolve any data queries
and to obtain relevant data where required.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias using cri-
teria described in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). We assessed included trials for ad-
equacy of sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome assessment,
incomplete outcome data, selective outcome reporting and other
potential sources of bias. For the other potential sources of bias
domain, we assessed for contamination, retention of clusters, re-
cruitment bias, and any other bias that may have been caused by
the design or conduct of the trial. For each domain, we made a
judgement of low risk, high risk or unclear risk of bias. We settled
any disagreements by discussion to reach consensus. We generated
’risk of bias’ summary figures using Review Manager 5 for each
study (Review Manager 2012). Review authors who had been in-
vestigators on an included study were not involved in assessing
risk of bias of that study.
Measures of treatment effect
We used risk ratios (RR) with 95% confidence interval (CI) as
measures of treatment effect for dichotomous outcomes. We used
hazard ratios (HR) with 95% CI for time to event data.
Unit of analysis issues
For cluster-RCTs, we extracted the effect measures (RR, HR) and
their 95% CIs that were adjusted for clustering, where available.
If unadjusted analyses had been performed, we sought to calcu-
late approximately correct analyses, by extracting data on number
of clusters, mean size of each cluster, primary outcome data and
estimates of the intracluster correlation coefficient (ICC). If an
approximately correct analysis was not possible, then we extracted
primary data and calculated RRs with 95% CIs.
Dealing with missing data
We recorded missing data due to loss of participants or clusters
from follow-up, with reasons where possible. We reported the
number of participants included in the final analysis as a propor-
tion of all randomised participants. We preferred Intention-to-
treat data. If these were not available, we recorded per-protocol
data.
Assessment of heterogeneity
We anticipated that different models of LTC in different countries
may lead to clinical heterogeneity. In the UK, residential homes
and nursing homes comprise residents who have different levels
of dependence and associated care needs. Furthermore, different
interventions for preventing delirium in older people in LTC were
likely to lead to methodological and statistical heterogeneity. For
example, there may be heterogeneity between strategies targeting
LTC residents or LTC facilities, or heterogeneity due to timing of
the delirium prevention intervention.
We planned separate categorisation and analysis of non-pharma-
cological and pharmacological, single and multicomponent inter-
ventions to help address trial heterogeneity. Due to clear clini-
cal heterogeneity (see Included studies), we did not conduct any
meta-analysis of the included trials.
Assessment of reporting biases
We sought clinical trial registrationdata and trial protocols to assess
potential reporting biases, and documented the funding source for
all trials to assist the assessment.
Data synthesis
Where adjusted HRs were presented, we analysed data using
generic inverse variance methods, deploying natural logarithms of
HRs and associated standard errors.
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We did not perform a meta-analysis because of clinical and
methodological differences between the trials.
Subgroup analysis and investigation of heterogeneity
See Differences between protocol and review.
Sensitivity analysis
See Differences between protocol and review.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; and Characteristics of ongoing studies tables.
Results of the search
The results of the search are outlined in aPRISMAdiagram (Figure
1). In this update, the search identified 238 records following
deduplication and assessment of titles and abstracts by Cochrane
Dementia Group information specialists and review authors. Of
these, 227 did not meet inclusion criteria and we excluded them.
We retrieved the full-text of the 11 remaining studies, six of which
we excluded (see Excluded studies) and three are ongoing (see
Ongoing studies), leaving one study (represented by two papers)
eligible for inclusion. This studywas added to the two studies from
the previous review (see Included studies), totalling three studies
for inclusion. We identified three potentially eligible trials that are
ongoing (see Ongoing studies).
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Figure 1. Study flow diagram. CDCIG: Cochrane Dementia and Cognitive Improvement Group; LTC: long-
term care; RCT: randomised controlled trial.
Included studies
We included three trials representing 3851 participants (Culp
2003; Lapane 2011; Siddiqi 2016). Two trials were complex sin-
gle-component, non-pharmacological, delirium prevention inter-
ventions (Culp 2003; Lapane 2011), and one trial was a com-
plex multicomponent non-pharmacological, delirium prevention
intervention (Siddiqi 2016).
One study was a cluster-RCT of a four-week hydration manage-
ment intervention (Culp 2003). It recruited 98 residents across
seven nursing homes in the US. All residents were considered el-
igible for inclusion; however, those with acute confusion at base-
line, terminal illness, uncontrolled diabetes, nasogastric or gastros-
tomy tube, severe renal failure, severe congestive heart failure, cur-
rent urinary tract infection or serum sodium less than 135 mEq/
L were excluded. The intervention was a hydration management
programme whereby an individual fluid intake goal was calculated
according to participant’s bodyweight. Seventy-five per cent of the
fluid intake goal was delivered with meals, and the remaining 25%
during non-meal times. Nursing staff were instructed on the treat-
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ment regimen. A research assistant calculated the fluid goal and
measured fluid intake randomly to ensure protocol compliance.
Control arm participants had no individual fluid intake goal. Fol-
low-up was at four weeks postrandomisation. The trial was funded
by the National Institute for Nursing Research.
One study was a cluster-RCT of the Geriatric Risk Assessment
MedGuide (GRAM) software program (Lapane 2011). This trial
included 3538 residents across 25 care homes in theUS.Medicare-
and Medicaid-certified nursing homes with contracts with Omni-
care pharmacies, 50 or more geriatric beds and few short-stay resi-
dents were considered for inclusion. All residents were considered
eligible; individual resident consent was assessed as not required
on the basis that the intervention involved a wholesale change
in clinical and administrative practices at the nursing home. The
GRAM was used to identify medications that may contribute to
delirium and falls risk for individual residents. Pharmacy auto-
matically generated a GRAM report within 24 hours of nursing
home admission. For those identified as being on medication con-
tributing to risk of delirium or falls, an automatic report was sent
to the pharmacist to coincide with a monthly visit to the nursing
home. A medication review was then undertaken at the visit and
a proactive monitoring plan was initiated by the care-home staff
to assess for medication side effects. Control nursing homes did
not receive the triggered pharmacist visit or proactive monitoring
plan. All outcomes were recorded electronically by participating
care-home staff over a 12-month period. The trial used resident
months rather than individuals as its unit of outcome measure-
ment. Results applied only to new admissions during 2004. The
trial was funded by the Agency for Healthcare Research and Qual-
ity and the National Institutes of Health Center for Research Re-
sources.
One study was a cluster randomised, controlled feasibility trial
of a 16-month educational package delivered to 14 independent
sector care homes in one Metropolitan district in the UK (Siddiqi
2016). All residents at the care homes were eligible to take part
unless they had severe communication difficulties, were unable to
communicate in English or were receiving end-of-life care. The
trial included 215 care home residents. The intervention called
’Stop delirium!’ was an enhanced educational package which in-
corporated multiple strategies to change practice (Siddiqi 2011).
A specialist delirium practitioner delivered three 20-minute in-
teractive educational sessions to care-home staff and facilitated
monthly staff working groups to identify targets for delirium pre-
vention and to develop bespoke solutions for each home. A delir-
ium champion was also trained at each home to deliver the edu-
cational sessions and facilitate the working groups. Control care
homes continued with care as usual and were offered the Stop
delirium! intervention package at the end of the trial. Delirium
assessments were conducted by researchers 16-months postran-
domisation, over a one-month period. Other outcomes were col-
lected electronically from care home records in a six-month period
starting 10-months postrandomisation, and hospitalisations were
obtained from routinely collected hospital data (hospital episode
statistics). The hospital admissions data and delirium incidence
data were obtained directly from correspondence with the author.
The trial was funded by theNational Institute of Health Research.
Excluded studies
In this update, we excluded six studies after assessing full-texts: two
were not specifically delirium prevention trials (García-Gollarte
2014; Snider 2012); one was not conducted in a LTC setting
(Faustino 2016); two studieswere notRCTs (Alagiakrishnan 2016;
NCT03066232); and one study was a summary paper of the orig-
inal review (González-Gil 2016).
Ongoing studies
We found three ongoing studies (Mestres Gonzalvo 2017;
NCT02994979; NCT03718156).
Risk of bias in included studies
Our assessment of risk of bias for the three included trials is pre-
sented in theCharacteristics of included studies table and in Figure
2. Risk of bias was mixed across the three trials; no trial was at low
risk of bias across all domains. There was no evidence of blinding
of trial participants and personnel in any of the three studies and
no evidence of blinding of assessors in two studies (Culp 2003;
Lapane 2011). Risk of bias for some domains was rated unclear,
due to insufficient information.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
One trial reported computer-generated randomisation and was at
low risk of selection bias (Siddiqi 2016). Two trials reported insuf-
ficient information on sequence generation or allocation conceal-
ment, and risk of selection bias was unclear (Culp 2003; Lapane
2011).
Blinding
Performance bias
Three trials did not report blinding for participants and personnel.
Two studies reported that it was not feasible to blind due to the
nature of the intervention (Culp 2003; Siddiqi 2016). All three
trials were rated at high risk of performance bias.
Detection bias
All three studies reported that outcome assessments were per-
formed by staff or researchers with knowledge of intervention al-
location, resulting in a high risk of detection bias (Culp 2003;
Lapane 2011: Siddiqi 2016).
Incomplete outcome data
Attrition bias was mixed across the three studies. Culp 2003 was at
high risk due to lack of reporting of informationon losses to follow-
up and intention-to-treat analysis. Lapane 2011 was at unclear
risk due to not reporting intention-to-treat analysis. Siddiqi 2016
was at low risk due to clear reporting of attrition and intention-
to-treat analysis.
Selective reporting
There was no evidence of selective outcome reporting in any of
the three trials, and all were at low risk of reporting bias.
Other potential sources of bias
Culp 2003 reported that staff alerted researchers to change in cog-
nition; therefore, identification of delirium was partly dependent
on staff knowledge. The nursing facility director recommended
which unit should be used in the study, introducing further po-
tential for bias. There was a significantly higher baseline urea:cre-
atinine ratio in the intervention group, indicating that this group
was more dehydrated at baseline and analyses were not adjusted
to account for this. No adjustments were made for the potential
effects of clustering. There may have been potential for between-
cluster contamination of the relatively simple hydration-based in-
tervention, and the investigators reported no measures to prevent
this. On the basis of these additional considerations, Culp 2003
was at high risk of other bias.
Lapane 2011 reported that only one trial cluster was lost and
they used Poisson regression to account for the cluster design.
Therefore, this trial was at low risk of other bias.
Siddiqi 2016 hadno evidence of other risk of bias andwas classified
at low risk.
Effects of interventions
See: Summary of findings for the main comparison
Single-component hydration intervention versus control for
preventing delirium in older people in institutional long-term
care; Summary of findings 2 Multicomponent educational
intervention compared to control for preventing delirium in older
people in institutional long-term care; Summary of findings
3 Single-component medication monitoring and adjustment
intervention versus control for preventing delirium in older people
in institutional long-term care
We did not pool data from the included studies because we con-
sidered the interventions to be too diverse.
Primary outcomes
Prevalence of delirium
One trial reported data on prevalence of delirium.
It was not possible to determine an effect on delirium prevalence
of the ’Stop delirium! intervention in Siddiqi 2016. Although the
RR favoured the intervention group, the result was very imprecise
(RR 0.57, 95% CI 0.15 to 2.19; 1 study, 160 participants; very
low-certainty evidence downgraded due to risk of bias and serious
imprecision; Summary of findings 2).
Incidence of delirium
All three trials reported data on incidence of delirium.
It was not possible to determine an effect on delirium incidence of
the hydration-based intervention inCulp 2003, because of the very
low-certainty of evidence (RR 0.85, 95%CI 0.18 to 4.00; 1 study,
98 participants; very low-certainty evidence downgraded due to
risk of bias and very serious imprecision; Summary of findings for
the main comparison).
The intervention (GRAM report, pharmacist-led medication re-
view and subsequent proactive monitoring plan) in Lapane 2011
was probably associated with a reduction in delirium incidence
compared to control (12-month HR 0.42, CI 0.34 to 0.51;
14Interventions for preventing delirium in older people in institutional long-term care (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
1 study, 7311 participant-months; moderate-certainty evidence
downgraded due to risk of bias; Summary of findings 3).
It was not possible to determine an effect on delirium incidence of
the ’Stop delirium! intervention in Siddiqi 2016 due to the very
low-certainty evidence (RR 0.62, 95% CI 0.16 to 2.39; 1 study,
137 resident months; downgraded due to risk of bias and very
serious imprecision). The study reported delirium incidence rates
for both groups. The intervention group had a delirium incidence
rate of 4.9 (95% CI 0.7 to 15) and the control group of 7.9 (95%
CI 1.4, 22) per 100-resident months (Summary of findings 2).
Severity of delirium
None of the included trials reported data on the severity of delir-
ium.
Mortality
Two trials reported data on mortality.
In the Lapane 2011 study, there was probably little or no effect
of the system for reviewing medication on mortality (HR 0.88,
CI 0.66 to 1.17; 1 study, 9412 participant-months; moderate-
certainty evidence downgraded due to imprecision; Summary of
findings 3).
In the Siddiqi 2016 study, there was probably little of no effect
of the ’Stop delirium! intervention on mortality (RR 0.82, 95%
CI 0.50 to 1.34; 1 study, 215 participants; moderate-certainty
evidence downgraded for imprecision; Summary of findings 2).
Secondary outcomes
Culp 2003 did not report data for any of our secondary outcomes.
Lapane 2011 reported data on hospital admissions and falls. There
was probably little or no effect of the intervention on hospital ad-
missions (HR 0.89, CI 0.72 to 1.10; 1 study, 7599 participant-
months; moderate-certainty evidence downgraded due to impre-
cision) or falls (HR 1.03, CI 0.92 to 1.15; 1 study, 2275 partici-
pant-months; low-certainty evidence downgraded for risk of bias
and imprecision) (Summary of findings 3). The hospitalisation
data was not separated into planned and unplanned admissions.
Therefore, the data reported were for all hospital admissions. The
study reported a 3% absolute reduction in use of opiates and use
of miscellaneous anticonvulsant medication and an approximate
4% reduction in tranquillisers, in the intervention homes but not
the control homes.
Siddiqi 2016 reported data on hospital admissions, quality of life,
direct costs, hospital resource use and monthly costs. The ’Stop
delirium! intervention was probably associated with a reduction
in hospital admissions compared to the control (RR 0.67, 95%
CI 0.57 to 0.79; 1 study, 494 participants; moderate-certainty ev-
idence downgraded due to indirectness; Summary of findings 2).
The indirectness in this study was because the hospital admissions
data were based on a national methodology to quantify admissions
from care homes, based on care-home postcode combined with an
age cut-off. This meant older adults living in the same postcode
area as a care home may have been included in the results. There-
fore, the data may have included people who were not part of the
trial. The study authors reported difficulty in obtaining accurate
care home-level and individual resident data. The hospitalisation
data were not separated by planned and unplanned admissions.
Therefore, the data reported were for all hospital admissions. The
intervention probably led to similar follow-up scores as the control
group on the quality of life measure, EQ-5D (MD 0.04, 95% CI
-0.09 to 0.17; 1 study, 160 participants: moderate-certainty evi-
dence downgraded due to risk of bias). The total cost of deliver-
ing the intervention was GBP 138 per resident. This included the
costs for care home staff and for the delirium practitioner. Over-
all, the hospital resource use for the intervention homes was lower
(estimated costs GBP 3281) than control homes (estimated costs
GBP 7210). These figures were estimated using national sources,
including the National Health Service reference cost databases. In
terms of monthly costs, the intervention homes cost per resident
was lower at GBP 219.72 compared with GBP 253.01 in control.
This included the cost of the intervention and the healthcare re-
source use.
Subgroup analyses
Limitations of data reporting precluded subgroup analysis for par-
ticipants with and without dementia.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Multicomponent educational intervention compared to control for preventing delirium in older people in institutional long- term care
Patient or population: prevent ing delirium in older people in inst itut ional long-term care
Setting: long-term care inst itut ions
Intervention: mult icomponent educat ional intervent ion
Comparison: control
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with control Risk with multicompo-
nent educational inter-
vention versus control
Prevalence of delirium
Assessed with: short-
CAM
Follow-
up: period prevalence
at 16 months postran-
domisat ion (assessed
over a 1-month period)
Study population RR 0.57
(0.15 to 2.19)
160a
(1 RCT)
⊕©©©
Very low b,c,d
-
71 per 1000 40 per 1000
(11 to 155)
Incidence of delirium
Assessed with: short-
CAM
Follow-up:16 months
postrandomisat ion (as-
sessed over a 1-month
period)
Study population RR 0.62
(0.16 to 2.39)
137e
(1 RCT)
⊕©©©
Very low b,c,d
Rate data reported in
paper:
4.9 (95% CI 0.7 to
15) per 100 resident-
months at
risk in intervent ion
homes and 7.9 (95% CI
1.4 to 22.0) per 100 res-
ident-months at risk in
control homes
100 per 1000 62 per 1000
(16 to 239)
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Severity of delirium
Assessed with: DRS-R-
98
Follow-up: 16 months
postrandomisat ion (as-
sessed over a 1-month
period)
N/ A N/ A - N/ A N/ A DRS-R-98 completed
for 12/ 13 short CAM
posit ive residents. All
rated as high severity
(score >15.25)
Mortality
Assessed with: care
home records
Follow-up: 10 months
postrandomisa-
t ion (recorded over a 6-
month period)
Study population RR 0.82
(0.50 to 1.34)
215
(1 RCT)
⊕⊕⊕©
Moderate c,d
-
250 per 1000 205 per 1000
(125 to 335)
Cognitive function
Assessed with: 6-CIT
N/ A - N/ A N/ A Baseline assessment
only.
Falls
Assessed with: care
home records
N/ A N/ A - N/ A N/ A Due to fall recording
issues, falls were not
analysed further follow-
ing baseline
Hospital admissions
Assessed with: hospital
episode stat ist ics
Follow-up: 10 months
postrandomisat ion (as-
sessed over a 6-month
period)
Study population RR 0.67
(0.57 to 0.79)
494f
(1 RCT)
⊕⊕⊕©
Moderate d,f
-
642 per 1000 430 per 1000
(366 to 507)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
6-CIT: 6-item Cognit ive Impairment Test; CAM: Confusion Assessment Method; CI: conf idence interval; DRS-R-98: Delirium Rating Scale, Revised; N/A: not applicable; RCT:
randomised controlled trial; RR: risk rat io; Short-CAM: Short Confusional Assessment Method.
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GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aTotal number included in the analysis.
bAssessed as high risk of methodological bias for blinding of part icipants and personnel.
cDowngraded due to imprecision.
dOne trial only so not possible to assess for consistency.
eNumber of part icipants was number of resident-months. Residents were assessed over a 1-month period, not all residents
completed assessments for the full month.
fDowngraded due to indirectness. The hospital admissions data were based on a nat ional methodology to quant if y admissions
f rom care homes, incorporat ing care-home postcode combined with an age cut-of f . This meant older adults living in the same
postcode area as a care home may have been included in the results.
1
8
In
te
rv
e
n
tio
n
s
fo
r
p
re
v
e
n
tin
g
d
e
liriu
m
in
o
ld
e
r
p
e
o
p
le
in
in
stitu
tio
n
a
l
lo
n
g
-te
rm
c
a
re
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
9
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Single-component medication monitoring and adjustment intervention versus control for preventing delirium in older people in institutional long- term care
Patient or population: people at risk of delirium in inst itut ional long-term care
Settings: long-term care inst itut ions
Intervention: single-component medicat ion monitoring and adjustment intervent ion
Comparison: control
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No of participant-
months
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with control Risk with single-
component medication
monitoring and adjust-
ment intervention ver-
sus control
Prevalence of delirium - - - - - Not measured
Incidence of delirium
NH-CAM
Follow-up: mean 12
months
Study population HR 0.42
(0.34 to 0.51)
7311
(1 study)a
⊕⊕⊕©
Moderateb,c,d
-
104 per 1000 45 per 1000
(37 to 54)
Severity of delirium - - - - - Not measured
Mortality
Follow-up: mean 12
months
Study population HR 0.88
(0.66 to 1.17)
9412
(1 study)a
⊕⊕⊕©
Moderatec,d,e
-
25 per 1000 22 per 1000
(17 to 29)
Cognitive function - - - - - Not measured
Falls
Fall events
Follow-up: mean 12
months
Study population RR 1.03
(0.92 to 1.15)
2275
(1 study)a
⊕⊕©©
Lowb,c,d
-
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523 per 1000 539 per 1000
(481 to 601)
Hospital admissions
Follow-up: mean 12
months
Study population HR 0.89
(0.72 to 1.10)
7599
(1 study)a
⊕⊕⊕©
Moderatec,d,e
-
55 per 1000 49 per 1000
(40 to 60)
* Therisk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; HR: hazard rat io; NH-CAM: Nursing Home Confusional Assessment Method; RR: risk rat io.
GRADE Working Group grades of evidence
High certainty: f urther research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate certainty: f urther research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low certainty: f urther research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low certainty: we are very uncertain about the est imate.
aNumber of part icipant months is def ined as the number of days f rom f irst assessment to the f irst outcome occurrence, the
last date in the nursing home, death date or 31 December 2004.
bAssessed as high risk of methodological bias for blinding of part icipants and personnel.
cOnly one trial, therefore, unable to assess consistency.
dLarge ef fect size observed but only one trial, therefore, not eligible for upgrade.
eDowngraded due to imprecision.
2
0
In
te
rv
e
n
tio
n
s
fo
r
p
re
v
e
n
tin
g
d
e
liriu
m
in
o
ld
e
r
p
e
o
p
le
in
in
stitu
tio
n
a
l
lo
n
g
-te
rm
c
a
re
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
9
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
D I S C U S S I O N
Summary of main results
Our review identified three RCTs of delirium prevention inter-
ventions for older people in institutional LTC, recruiting 3851
participants.
One small cluster-RCT (98 participants) of a hydration-based in-
tervention was not able to show any reduction in delirium inci-
dence in the intervention group compared to control because of
very serious imprecision in the result. Additionally, the analysis
was not adjusted for the effects of clustering and there were serious
limitations in trial design, so there is a high level of uncertainty
associated with the effect estimate. Importantly, the investigators
reported that both intervention and control groups were consum-
ing approximately the same volume of fluids over the follow-up
period, and only 51% of intervention participants had 90% or
greater compliance with the fluid goal. Previous research has iden-
tified that many LTC residents do not consume adequate fluid
(Armstrong-Esther 1996), and this resultmay indicate that achiev-
ing target fluid intake in care-home residents is challenging, even
in the context of a clinical trial.
One large cluster-RCT (3538 participants) of a computerised sys-
tem to identify medications that may contribute to delirium risk
and trigger a pharmacist-led medication review found moderate-
certainty evidence of a large reduction in delirium incidence but
of little or no effect on hospital admissions, mortality or falls.
One feasibility cluster-RCT (215 participants) of an enhanced ed-
ucational package to identify delirium risk targets and develop be-
spoke solutions specific to individual care homes, was not able to
show any reduction in delirium incidence or prevalence due to the
serious imprecision in the results. There was moderate-certainty
evidence of a reduction in hospital admissions. The hospital ad-
missions data are based on a national methodology to quantify
admissions from care homes, incorporating care-home postcode
combined with an age cut-off. This means older adults living in
the same postcode area as a care home may have been included
in the results. Therefore, the data may have included people who
were not part of the trial and did not receive the intervention or
control.
Overall completeness and applicability of
evidence
The small number of included trials represented a limited body
of evidence on the effectiveness of interventions for preventing
delirium in older people in institutional LTC. We identified only
two single-component non-pharmacological interventions with
methodological limitations and one multicomponent non-phar-
macological intervention. We did not find any pharmacological
delirium prevention interventions for this population. Two of the
trials were conducted in the US and one in the UK. International
differences in the organisation of LTC may mean that the results
are not directly applicable to other settings.
Quality of the evidence
WeusedGRADEpro software to inform the generationof evidence
certainty statements.
On the basis of a single RCTwith serious limitations in trial design
and very imprecise results, there was very low-certainty evidence
on the effectiveness of hydration-based interventions for reducing
the incidence of delirium in older people in institutional LTC.The
evidence was downgraded two levels due to serious imprecision.
Therefore, it was not possible to draw firm conclusions about this
intervention (Summary of findings for the main comparison).
On the basis of one large RCT, there was moderate-certainty ev-
idence that a single-component medication monitoring and ad-
justment intervention may have reduced the incidence of delirium
in older people in institutional LTC (Summary of findings 3).
On the basis of one large RCT, there was moderate-certainty evi-
dence that a single-componentmedicationmonitoring and adjust-
ment intervention did not appear to be associated with reduced
hospitalisation or mortality for older people in institutional LTC.
There was low-certainty evidence that the intervention did not
appear to be associated with falls (Summary of findings 3).
On the basis of a single RCT, there was very low-certainty evidence
on the effectiveness of an enhanced educational intervention for
reducing delirium incidence or prevalence in older people in LTC.
The evidence was downgraded two levels due to serious impreci-
sion. Therefore, it was not possible to draw firm conclusions about
this intervention (Summary of findings 2).
On the basis of a single RCT, there was moderate-certainty ev-
idence that an enhanced educational intervention may have re-
duced hospitalisations in older people in LTC. The evidence was
downgraded due to indirectness. There was moderate-certainty
evidence that the intervention did not appear to be associated with
reduced mortality (Summary of findings 2).
Potential biases in the review process
This review has followed Cochrane procedures and there were
only minor amendments to the review protocol following initial
publication. The very small number of included trials precluded
an accurate assessment of consistency of results or a statistical
assessment of reporting bias.
Agreements and disagreements with other
studies or reviews
21Interventions for preventing delirium in older people in institutional long-term care (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
To our knowledge there are no previous systematic reviews on the
effectiveness of delirium prevention interventions for older people
in institutional LTC settings.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Introduction of a software-based intervention to identify medi-
cations that could contribute to delirium risk, so that a pharma-
cist-led medication review and monitoring plan can be initiated,
was probably associated with a reduction in delirium incidence for
older people in institutional LTC without affecting hospital ad-
missions, falls or mortality. This is based on one large randomised
controlled trial (RCT) in the US and the intervention may not
be practical in other countries which do not have comparable in-
formation technology services available in care homes. One small
RCT of a weight-based hydration intervention for older people in
nursing homes had serious methodological limitations and poor
concordance with the intervention; it is not possible to determine
the usefulness of this approach. The enhanced educational inter-
vention delivering training sessions to staff and developing tar-
gets for delirium prevention bespoke to each care home, was not
able to provide any clear evidence for the reduction of delirium
episodes or mortality. The intervention may be able to reduce hos-
pital admissions, although, due to the possible inclusion of hospi-
tal admissions data from non-trial participants, further research is
required.
Implications for research
There is very limited evidence on the effectiveness of interventions
for preventing delirium in older people in institutional LTC. Fur-
ther large trials of computerised medication management inter-
ventions and of enhanced educational interventions are justified.
These trials should be supported by research investigating imple-
mentation across different care systems.
Delirium is a common and very distressing condition with dev-
astating outcomes. Interventions that are effective in preventing
delirium are of high importance. Future studies should pay par-
ticular attention to accurate recording of delirium incidence and
prevalence. The challenges of conducting research in LTC settings
are well described in the international literature (Lam 2018). In
the UK, the lack of a systematic recording of care home residency
in health and care data systems makes it difficult to use these
methods to reliably ascertain outcomes such as hospital admission
(Burton 2018). Researchers need to be aware of the limitations of
the methods they select to collect outcome data and consider how
these may be overcome when designing trials.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Culp 2003
Methods Cluster-randomised controlled trial with nursing home as the unit of randomisation
Participants 98 residents of 7 care homes in Iowa, USA
Mean age: 84.5 (SD 9.3) years in intervention group; 83.8 (SD 8.1) years in control
group
54.7% women in intervention group; 53.3% women in control group
Interventions Intervention group: 4-week weight-based hydration management intervention for nurs-
ing-home residents. Individual fluid intake goal was calculated according to bodyweight.
75% of the fluid intake goal was delivered with meals, the remaining 25% during non-
meal times. Nursing staff were instructed on the treatment regimen. A research assistant
calculated the fluid goal and measured fluid intake randomly to ensure protocol com-
pliance
Control group: no individual fluid intake goal.
Outcomes Incidence of delirium, measured using the NEECHAMConfusion Scale (Neelon 1996)
.
Outcomes recorded at 4 weeks postrandomisation.
Notes Funding source: National Institute for Nursing Research
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided on generation of
allocation sequence
Allocation concealment (selection bias) Unclear risk Cluster randomised trial. Unclear if all care
homes recruited prior to randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants or personnel (or both) aware of
allocation to intervention or control group
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Assessments made by the research team
who were not blind to intervention alloca-
tion
Incomplete outcome data (attrition bias)
All outcomes
High risk No information on loss to follow-up. No
intention-to-treat analysis
27Interventions for preventing delirium in older people in institutional long-term care (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Culp 2003 (Continued)
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Other bias High risk Staff alerted researchers to change in cog-
nition so dependent on staff knowledge.
Nursing facility director recommended
which unit should be used in the study. A
higher urea:creatinine ratio in the interven-
tion group, indicating that this group were
more dehydrated at baseline. No adjust-
ment made for effects of clustering. Poten-
tial for between-cluster contamination of
the relatively simple hydration-based inter-
vention, and measures to prevent this were
not reported by the investigators
Lapane 2011
Methods Cluster-randomised controlled trial with nursing home as the unit of randomisation
Participants 3538 residents of 25 nursing homes in Virginia, USA, recruited between 2003 and 2004
Medicare- and Medicaid-certified nursing homes with contracts with Omnicare phar-
macies, ≥ 50 geriatric beds and few short-stay residents were considered for inclusion
73.9% women
39.0% aged ≥ 85 years
Interventions Intervention group: GRAM software used to identify resident-specific medications that
may contribute to delirium and falls risk. Pharmacy automatically generated GRAM
report within 24 hours of nursing-home admission. For those who triggered GRAM
resident assessment protocols for delirium or falls risk, an automatic report was sent
to the pharmacist to coincide with a monthly visit to the nursing home. A medication
review was then undertaken at the visit and a proactive monitoring plan was initiated by
the care home staff to assess for medication adverse effects
Control group: nursing homes did not receive the triggered pharmacist visit or proactive
monitoring plan
Outcomes Incidence of delirium, measured using the NH-CAM (Dosa 2007)
Fall events, measured using MDS records
Hospital admissions, measured using MDS records.
Mortality, measured using MDS records.
The trial used residentmonths (defined as the number of days fromdate of first assessment
to the first outcome occurrence, the last date in the nursing home, the death date or 31
December 2004), rather than individuals as its unit of outcome measurement
Results applied only to new admissions during 2004.
All outcomes were recorded electronically by participating care-home staff over a 12-
month period
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Lapane 2011 (Continued)
Notes Funding source: Agency for Healthcare Research and Quality and theNational Institutes
of Health Center for Research Resources
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of allocation sequence generation
not provided.
Allocation concealment (selection bias) Unclear risk Unclear if all care homes recruited prior to
randomisation.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants or personnel (or both) aware
of allocation to intervention or routine care
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Outcomes assessed using data from the
minimum dataset and assessments were
made by staff aware of allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 1 cluster lost.No informationon intention-
to-treat analysis
Selective reporting (reporting bias) Low risk No evidence of selective outcome report-
ing.
Other bias Low risk Only 1 cluster was lost. Poisson regression
accounting for the cluster design was used
Siddiqi 2016
Methods Cluster-randomised controlled trial with care home as the unit of randomisation
Participants 215 participants from 14 independent sector care homes in 1 metropolitan district in
the UK (residential and nursing care)
Mean age: 83.9 (SD 8.1) years
69.3% women
96.7% white British ethnicity
Interventions Intervention group: Stop Delirium! Multicomponent educational package, multiple
strategies to change practice. Delivered to care homes over 16-months. Specialist delir-
ium practitioner delivered 3 × 20-minute interactive educational sessions and facilitated
working groups with care home staff - to identify delirium prevention targets and develop
bespoke solutions for each home. A ’delirium champion’ was also trained at each home.
It aims to modify key resident and environmental delirium risk factors (pain, infections,
dehydration, poor nutrition, constipation, polypharmacy, sensory impairment, limited
mobility and sleep disturbance) by improving the quality of care
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Siddiqi 2016 (Continued)
Control group: care as usual. Stop delirium package offered at the end of the trial
Delirium assessments: 16-months postrandomisation, over a 1-month period
Other outcomes: collected electronically from care home records in a 6-month period
starting 10 months postrandomisation, and hospitalisations were obtained from rou-
tinely collected hospital data (hospital episode statistics)
Outcomes Delirium point prevalence (at baseline)
Delirium period prevalence assessed by CAM
Delirium incidence assessed by CAM and case note review
Delirium severity assessed using the DRS-R-98
Proportion of residents with ≥ 1 CAM-positive assessment during follow-up
Hospital admissions (6 months and 16 months)
Number of medications
Mortality
Feasibility of baseline and outcome assessments
Health and social care resource use
Quality of life using EQ-5D, SCRQoL, and DEMQoL-5D
Intervention delivery
Notes National Institute of Health Research for Patient Benefit Programme
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Homes were randomised on a 1:1 basis
using a computer-generated minimisation
programme which stratified homes based
on care home size and percentage of resi-
dents with dementia
Allocation concealment (selection bias) Low risk Computer-generated minimisation pro-
gramme by Leeds Clinical Trials Research
Unit
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants or personnel (or both) were
aware of allocated intervention due to the
nature of the intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Authors reported that it was not possible to
blind researchers collecting outcome mea-
sures to group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk 215 residents recruited, 160 included in
analysis. Attrition of participants between
recruitment and follow-up was 27.2% for
the intervention group and 24.1% for the
control group. Similar reasons for dropout
across both groups
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Siddiqi 2016 (Continued)
Selective reporting (reporting bias) Low risk Study protocol was available and changes to
the original protocol were outlined, which
included the introductionof a secondphase
of resident recruitment 12 months after
randomisation because of a high attrition
rate, and conducting structured case note
reviews in order to explore the possibil-
ity that reliance on face-to-face assessments
alone might be underestimating delirium
Other bias Low risk No evidence of other bias.
CAM: Confusional Assessment Method; DEMQoL-5D: Dementia Quality of Life - 5 Dimension; DRS-R-98: Delirium Rating
Scale Revised-98; EQ-5D: EuroQol-5-Dimensions; GRAM: Geriatric Risk Assessment MedGuide; MDS: minimum data set;
NEECHAM: Neelon and Champagne; NH-CAM: Nursing Home Confusion Assessment Method; SCRQoL: Social Care Related
Quality of Life; SD: standard deviation.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alagiakrishnan 2016 Not an RCT.
Faustino 2016 Trial not conducted in a long-term care setting.
García-Gollarte 2014 Not a delirium prevention trial.
González-Gil 2016 Summary paper of original review.
Greendyke 1986 Not a delirium prevention trial.
Grover 2011 Not a delirium prevention trial.
Hofferberth 1989 Not a delirium prevention trial.
Isaia 2009 Trial not conducted in a long-term care setting.
Kim 2010 Not a delirium prevention trial.
Marcantonio 2010 Trial not conducted in a long-term care setting.
Mittal 2004 Not a delirium prevention trial.
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(Continued)
Moretti 2004 Not a delirium prevention trial.
NCT03066232 Not an RCT.
Overshott 2010 Not a delirium prevention trial.
Pellfolk 2010 Not a delirium prevention trial.
Snider 2012 Not a delirium prevention trial.
Tahir 2010 Not a delirium prevention trial.
Ushijima 2008 Not a delirium prevention trial.
Yoon 2011 Not a delirium prevention trial.
RCT: randomised controlled trial.
Characteristics of ongoing studies [ordered by study ID]
Mestres Gonzalvo 2017
Trial name or title Supporting Clinical Rules Engine in the Adjustment of Medication (SCREAM)
Methods Cluster-RCT of nursing homes in the Netherlands
Participants Nursing home residents
Interventions Intervention group: clinical decision support system will be used to screen medication lists, laboratory values
and medical history in order to obtain potential clinically relevant remarks. The remarks will be sent to the
main physician and feedback will be provided whether the advice was followed or not
Control group: regular care.
Outcomes Hospital referrals, delirium, falls, and deaths
Starting date June 2013
Contact information Carlota Mestres Gonzalvo; c.mestresgonzalvo@zuyderland.nl
Notes The complete SCREEN project (Supporting clinical rules in the evaluation of elderly patients with neu-
ropsychiatric disorders), which includes the SCREAM study, is supported by a grant from the ZonMw (the
Netherlands Organisation for Health Research and Development) (Grant number: 113101001)
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NCT02994979
Trial name or title Nursing assistant intervention to prevent delirium in nursing homes
Methods People on 17 long-term care units at a large, urban nursing home who experience onset of an acute change
in condition according to established criteria, will be screened
Delirium will be assessed 5 days a week by a research assistant blinded to study hypotheses and group
assignment. Cognitive and physical function decline and hospital transfer will be ascertained during 1-month
follow-up
Participants Nursing home residents
Interventions Intervention group: multicomponent intervention targeting delirium risk factors (immobility, cognitive im-
pairment, dehydration, undernutrition, sleep and medication use). Daily visits from an Elder Life Specialist,
a mobile Certified Nursing Assistant trained to provide services to counter risks for delirium, for the duration
of the acute illness and for 1 week following, in collaboration with the patient’s primary medical and nursing
team
Control group: usual care from the unit-based nurses and the patient’s primary care team
Outcomes Delirium incidence measured by Confusional Assessment Method
Physical function, cognitive function, hospital admission
Starting date November 2016
Contact information Kimberly Judon, kjudon@jewishhome.org
Notes
NCT03718156
Trial name or title The Prevention Program for Alzheimer’s Related Delirium (PREPARED) trial
Methods 4-year, cluster RCT of long-term care facilities in Canada. Clusters will be assigned to either the PREPARED
trial intervention group or the control (usual care) group. 40-50 long-term care facilities will be recruited.
Residents will be assessed weekly for a follow-up of 18 weeks
Participants Long-term care residents
Interventions Intervention group: multicomponent intervention provided to nursing staff working in long-term care facil-
ities. The intervention consists of 4 components: a decision tree, an instruction manual, a training package
and a tool kit. Nursing staff will be trained to adjust the therapeutic nursing plans for residents in the in-
tervention group, by providing optimal stimulation (including, surveying the use of glasses and hearing aids
and room lighting and space organisation), and by assessing the presence of modifiable delirium risk factors
(antipsychotic use, sensory impairment, restraint use and dehydration), then taking specific action when a
risk factor is identified
Control group: care as usual. Staff in this groupwill be providedwith the PREPAREDtrial training programme
at the end of follow-up
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NCT03718156 (Continued)
Outcomes Incidence of delirium measured by Confusional Assessment Method
Delirium severity measured by Delirium Index
Delirium episode duration and number of delirium episodes
Falls, cognitive functioning, change in functional autonomy, change in level of social engagement
Starting date June 2018
Contact information Machelle Wilchesky; Machelle.Wilchesky@mcgill.ca
Notes
RCT: randomised controlled trial.
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D A T A A N D A N A L Y S E S
Comparison 1. Single-component hydration intervention versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Incidence of delirium 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
Comparison 2. Single-component medication monitoring and adjustment intervention versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Incidence of delirium 1 Hazard Ratio (Random, 95% CI) Subtotals only
2 Mortality 1 Hazard Ratio (Random, 95% CI) Subtotals only
3 Falls 1 Hazard Ratio (Random, 95% CI) Subtotals only
4 Hospital admissions 1 Hazard Ratio (Random, 95% CI) Subtotals only
Comparison 3. Multicomponent delirium prevention intervention (MCI) versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Prevalence of delirium 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2 Incidence of delirium 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3 Mortality 1 Risk Ratio (M-H, Random, 95% CI) Subtotals only
4 Quality of Life EQ-5D 1 Mean Difference (IV, Random, 95% CI) Subtotals only
5 Hospital admissions 1 Odds Ratio (M-H, Random, 95% CI) Subtotals only
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Analysis 1.1. Comparison 1 Single-component hydration intervention versus control, Outcome 1 Incidence
of delirium.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 1 Single-component hydration intervention versus control
Outcome: 1 Incidence of delirium
Study or subgroup Hydration Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Culp 2003 3/53 3/45 0.85 [ 0.18, 4.00 ]
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours hydration Favours control
Analysis 2.1. Comparison 2 Single-component medication monitoring and adjustment intervention versus
control, Outcome 1 Incidence of delirium.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 2 Single-component medication monitoring and adjustment intervention versus control
Outcome: 1 Incidence of delirium
Study or subgroup log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Lapane 2011 -0.8675006 (0.101) 0.42 [ 0.34, 0.51 ]
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours monitoring Favours control
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Analysis 2.2. Comparison 2 Single-component medication monitoring and adjustment intervention versus
control, Outcome 2 Mortality.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 2 Single-component medication monitoring and adjustment intervention versus control
Outcome: 2 Mortality
Study or subgroup log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Lapane 2011 -0.1278334 (0.144) 0.88 [ 0.66, 1.17 ]
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours monitoring Favours control
Analysis 2.3. Comparison 2 Single-component medication monitoring and adjustment intervention versus
control, Outcome 3 Falls.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 2 Single-component medication monitoring and adjustment intervention versus control
Outcome: 3 Falls
Study or subgroup log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Lapane 2011 0.0295588 (0.0569) 1.03 [ 0.92, 1.15 ]
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours monitoring Favours control
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Analysis 2.4. Comparison 2 Single-component medication monitoring and adjustment intervention versus
control, Outcome 4 Hospital admissions.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 2 Single-component medication monitoring and adjustment intervention versus control
Outcome: 4 Hospital admissions
Study or subgroup log [Hazard Ratio] Hazard Ratio Weight Hazard Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
Lapane 2011 -0.1165338 (0.106) 0.89 [ 0.72, 1.10 ]
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours monitoring Favours control
Analysis 3.1. Comparison 3 Multicomponent delirium prevention intervention (MCI) versus control,
Outcome 1 Prevalence of delirium.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 3 Multicomponent delirium prevention intervention (MCI) versus control
Outcome: 1 Prevalence of delirium
Study or subgroup Educational MCI Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Siddiqi 2016 3/75 6/85 0.57 [ 0.15, 2.19 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours educational MCI Favours Control
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Analysis 3.2. Comparison 3 Multicomponent delirium prevention intervention (MCI) versus control,
Outcome 2 Incidence of delirium.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 3 Multicomponent delirium prevention intervention (MCI) versus control
Outcome: 2 Incidence of delirium
Study or subgroup Educational MCI Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Siddiqi 2016 3/61 6/76 0.62 [ 0.16, 2.39 ]
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours educational MCI Favours Control
Analysis 3.3. Comparison 3 Multicomponent delirium prevention intervention (MCI) versus control,
Outcome 3 Mortality.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 3 Multicomponent delirium prevention intervention (MCI) versus control
Outcome: 3 Mortality
Study or subgroup Educational MCI Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Siddiqi 2016 21/103 28/112 0.82 [ 0.50, 1.34 ]
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours educational MCI Favours control
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Analysis 3.4. Comparison 3 Multicomponent delirium prevention intervention (MCI) versus control,
Outcome 4 Quality of Life EQ-5D.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 3 Multicomponent delirium prevention intervention (MCI) versus control
Outcome: 4 Quality of Life EQ-5D
Study or subgroup Educational MCI Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Siddiqi 2016 75 0.42 (0.39) 85 0.38 (0.42) 0.04 [ -0.09, 0.17 ]
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours educational MCI Favours control
Analysis 3.5. Comparison 3 Multicomponent delirium prevention intervention (MCI) versus control,
Outcome 5 Hospital admissions.
Review: Interventions for preventing delirium in older people in institutional long-term care
Comparison: 3 Multicomponent delirium prevention intervention (MCI) versus control
Outcome: 5 Hospital admissions
Study or subgroup Educational MCI Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Siddiqi 2016 121/282 136/212 0.42 [ 0.29, 0.61 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours educational MCI Favours control
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A P P E N D I C E S
Appendix 1. Sources searched and search strategies
Source Search strategy Hits retrieved
1. ALOIS (www.medicine.ox.ac.uk/alois)
(Date of most recent search: 27 February
2019)
delirium Jul 2012: 96
Apr 2013: 9
Nov 2016: 8
Feb 2018: 3
Feb 2019: 3
2. MEDLINE In-process Nov 2016:and
other non-indexed citations and MED-
LINE 1950 - present (OvidSP)
(Date of most recent search: 27 February
2019)
1. Delirium/
2. deliri*.mp.
3. “acute confusion*”.ti,ab.
4. “acute organic psychosyndrome”.ti,ab.
5. “acute brain syndrome”.ti,ab.
6. “metabolic encephalopathy”.ti,ab.
7. “acute psycho-organic syndrome”.ti,ab.
8. “clouded state”.ti,ab.
9. “clouding of consciousness”.ti,ab.
10. “exogenous psychosis”.ti,ab.
11. “toxic psychosis”.ti,ab.
12. “toxic confusion”.ti,ab.
13. Delirium, Dementia, Amnestic, Cog-
nitive Disorders/su [Surgery]
14. obnubilat*.ti,ab.
15. or/1-14
16. Primary Prevention/
17. prevent*.mp.
18. reduc*.ti,ab.
19. stop*.ti,ab.
20. taper*.ti,ab.
21. avoid*.ti,ab.
22. “cut* down”.ti,ab.
23. or/16-22
24. 15 and 23
25. randomized controlled trial.pt.
26. controlled clinical trial.pt.
27. randomi?ed.ab.
28. placebo.ab.
29. drug therapy.fs.
30. randomly.ab.
31. trial.ab.
32. groups.ab.
33. or/25-32
34. (animals not (humans and animals)).
sh.
35. 33 not 34
36. 24 and 35
Jul 2012: 821
Apr 2013: 118
Nov 2016: 120
Feb 2018: 263
Feb 2019: 192
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(Continued)
3. Embase
1980 - 2019 February 26 (OvidSP)
(Date of most recent search: 27 February
2019)
1. Delirium/
2. deliri*.mp.
3. “acute confusion*”.ti,ab.
4. “acute organic psychosyndrome”.ti,ab.
5. “acute brain syndrome”.ti,ab.
6. “metabolic encephalopathy”.ti,ab.
7. “acute psycho-organic syndrome”.ti,ab.
8. “clouded state”.ti,ab.
9. “clouding of consciousness”.ti,ab.
10. “exogenous psychosis”.ti,ab.
11. “toxic psychosis”.ti,ab.
12. “toxic confusion”.ti,ab.
13. Delirium, Dementia, Amnestic, Cog-
nitive Disorders/su [Surgery]
14. obnubilat*.ti,ab.
15. or/1-14
16. primary prevention/
17. prevent*.mp.
18. reduc*.ti,ab.
19. stop*.ti,ab.
20. taper*.ti,ab.
21. avoid*.ti,ab.
22. “cut* down”.ti,ab.
23. or/16-22
24. 15 and 23
25. randomized controlled trial/
26. random*.ti,ab.
27. placebo.ti,ab.
28. trial.mp.
29. controlled clinical trial/
30. or/25-29
31. 24 and 30
Jul 2012: 835
Apr 2013: 161
Nov 2016: 191
Feb 2018: 562
Feb 2019: 366
4. PsycINFO
1806 - February week 4 2019 (OvidSP)
(Date of most recent search: 27 February
2019)
1. Delirium/
2. deliri*.mp.
3. “acute confusion*”.ti,ab.
4. “acute organic psychosyndrome”.ti,ab.
5. “acute brain syndrome”.ti,ab.
6. “metabolic encephalopathy”.ti,ab.
7. “acute psycho-organic syndrome”.ti,ab.
8. “clouded state”.ti,ab.
9. “clouding of consciousness”.ti,ab.
10. “exogenous psychosis”.ti,ab.
11. “toxic psychosis”.ti,ab.
12. “toxic confusion”.ti,ab.
13. obnubilat*.ti,ab.
14. or/1-13
15. Prevention/
16. prevent*.mp.
Jul 2012: 163
Apr 2013: 19
Nov 2016: 16
Feb 2018: 45
Feb 2019: 17
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(Continued)
17. reduc*.ti,ab.
18. stop*.ti,ab.
19. taper*.ti,ab.
20. avoid*.ti,ab.
21. “cut* down”.ti,ab.
22. or/15-21
23. 14 and 22
24. random*.mp.
25. trial.mp.
26. placebo*.mp.
27. group.ab.
28. or/24-27
29. 23 and 28
5. CINAHL (EBSCOhost)
(Date of most recent search: 27 February
2019)
S1 (MH “Delirium”) OR (MH “Delir-
ium Management (Iowa NIC)”) OR (MH
“Delirium, Dementia, Amnestic, Cogni-
tive Disorders/SU”)
S2 TX deliri*
S3 TX “acute confusion*”
S4 TX “acute organic psychosyndrome”
S5 TX “acute brain syndrome”
S6 TX “metabolic encephalopathy”
S7 TX “acute psycho-organic syndrome”
S8 TX “clouded state”
S9 TX “clouding of consciousness”
S10 TX “exogenous psychosis”
S11 TX “toxic psychosis”
S12 TX “toxic confusion”
S13 TX obnubilat*
S14 S1 or S2 or S3 or S4 or S5 or S6 or S7
or S8 or S9 or S10 or S11 or S12 or S13
S15 (MH “Preventive Trials”) OR (MH
“Preventive Health Care”)
S16 TX prevent*
S17 TX reduc*
S18 TX stop*
S19 TX taper*
S20 TX avoid*
S21 TX “cut* down”
S22 S15 or S16 or S17 or S18 or S19 or
S20 or S21
S23 S14 and S22
S24 TX random*
S25 TX placebo
S26 TX trial
S27 (MH “Clinical Trials”) OR (MH “In-
tervention Trials”)
S28 S24 or S25 or S26 or S27
S29 S23 and S28
Jul 2012: 189
Apr 2013: 0
Nov 2016: 2
Feb 2018: 86
Feb 2019: 115
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(Continued)
6. Web of Science Core Collection (ISI
Web of Science)
(Date of most recent search: 27 February
2019)
Topic=(deliri* OR “acute confusion*”
OR “acute organic psychosyndrome” OR
“acute brain syndrome”OR“metabolic en-
cephalopathy” OR “acute psycho-organic
syndrome”OR “clouded state”OR “cloud-
ing of consciousness” OR “exogenous psy-
chosis” OR “toxic psychosis” OR “toxic
confusion” OR obnubilat*) AND Topic=
(prevent* OR reduc* OR stop* OR taper*
OR avoid* OR “cut* down”) ANDTopic=
(random* or placebo or “double-blind” or
trial OR groups OR “controlled study”OR
“time series”OR “Comparative Study”OR
“Pretest-Posttest Design”)
Timespan=All Years. Databases=
SCI-EXPANDED, SSCI, A&HCI, CPCI-
S, CPCI-SSH, BKCI-S, BKCI-SSH
Lemmatization=On
Jul 2012: 654
Apr 2013: 163
Nov 2016: 176
Feb 2018: 620
Feb 2019: 325
7. LILACS (BIREME)
(Date of most recent search: 27 February
2019)
randomlyORrandomisedORrandomized
OR trial OR ensaio clínicoOR control OR
controlled [Words] and delirium OR de-
lious OR deliria OR delirio OR loucura
[Words]
Jul 2012: 47
Apr 2013: 1
Nov 2016: 5
Feb 2018: 8
Feb 2019: 6
8. CENTRAL (the Cochrane Library) (Issue
2 of 12, 2019)
(Date of most recent search: 27 February
2019)
#1 MeSH descriptor Delirium, this term
only
#2 deliri*
#3 “acute confusion*”
#4 “acute organic psychosyndrome”
#5 “acute brain syndrome”
#6 “metabolic encephalopathy”
#7 “acute psycho-organic syndrome”
#8 “clouded state”
#9 “clouding of consciousness”
#10 “exogenous psychosis”
#11 “toxic psychosis”
#12 “toxic confusion”
#13 obnubilat*
#14 (#1 OR #2 OR #3 OR #4 OR #5 OR
#6 OR #7 OR #8 OR #9 OR #10 OR #11
OR #12 OR #13)
#15 MeSH descriptor Primary Prevention,
this term only
#16 prevent*
#17 reduc*
#18 stop*
#19 taper*
#20 avoid*
Jul 2012: 230
Apr 2013: 7
Nov 2016: 42
Feb 2018: 80
Feb 2019: 365
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(Continued)
#21 “cut* down”
#22 (#15 OR #16 OR #17 OR #18 OR #
19 OR #20 OR #21)
#23 (#14 AND #22), trials
9. Clinicaltrials.gov (
www.clinicaltrials.gov)
(Date of most recent search: 27 February
2019)
care home OR institutionalised OR insti-
tutionalized OR long term care OR home
| Interventional Studies | delirium OR
toxic psychosis OR toxic confusion OR
metabolic encephalopathy OR clouded
state OR exogenous psychosis | Senior
Jul 2012: 156
Apr 2013: 23
Nov 2016: 11
Feb 2018: 27
Feb 2019: 12
10. ICTRP Search Portal (apps.who.int/
trialsearch) (includes: Australian New
Zealand Clinical Trials Registry; Clinical-
Trials.gov; ISRCTN;Chinese Clinical Trial
Registry; Clinical Trials Registry - India;
Clinical Research Information Service - Re-
public of Korea; German Clinical Trials
Register; Iranian Registry of Clinical Tri-
als; Japan Primary Registries Network; Pan
African Clinical Trial Registry; Sri Lanka
Clinical Trials Registry; The Netherlands
National Trial Register)
(Date of most recent search: 27 February
2019)
care home OR institutionalised OR insti-
tutionalized OR long term care OR home
| Interventional Studies | delirium OR
toxic psychosis OR toxic confusion OR
metabolic encephalopathy OR clouded
state OR exogenous psychosis
Jul 2012: 72
Apr 2013: 0
Nov 2016: 1
Feb 2018: 5
Feb 2019: 1
TOTAL before deduplication July 2012: 3263
April 2013: 501
Nov 2016: 572
Feb 2018: 1699
Feb 2019: 1037
TOTAL: 7027
TOTAL after deduplication and first assessment by CDCIG Information Specialists July 2012: 120
April 2013: 15
Nov 2016: 31
Feb 2018: 70
Feb 2019: 2
TOTAL: 238
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WH A T ’ S N E W
Date Event Description
27 February 2019 New search has been performed The most recent search for this review was performed
on 27 February 2019
27 February 2018 New citation required and conclusions have changed Review updated and conclusions changed. One study
added to the review
Review authors have changed. One existing author and
four new authors completed this update
C O N T R I B U T I O N S O F A U T H O R S
For this 2018 update contributions were as follows.
RW and NS screened all titles and abstracts.
RW and JKB assessed full texts for inclusion.
RW, JKB and JL extracted data for included studies and assessed risk of bias.
RW completed ’Summary of findings’ tables and generated GRADE Evidence Profiles.
All authors contributed to the drafting and editing of this update.
D E C L A R A T I O N S O F I N T E R E S T
RW: none.
JKB is an author on one of the included studies. She had no part in data extraction or assessing risk of bias for this study.
NR: none.
YLP: none.
JL: none.
NS was chief investigator for a National Institute for Health Research (NIHR) Research for Patient Benefit (RfPB) grant to investigate
the effects of a delirium prevention intervention for older people in long-term care and is an author on one of the included studies.
She had no part in decisions about inclusion, data extraction, risk of bias or interpretation of findings from this study. She provided
additional unpublished data on hospital admissions, at the request of RW.
46Interventions for preventing delirium in older people in institutional long-term care (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• NIHR, UK.
This update was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the
Cochrane Dementia and Cognitive Improvement group. The views and opinions expressed therein are those of the authors and do
not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service or the Department of Health
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
2019 update of the review
We rated the blinding section of the risk of bias in two parts (blinding of participants and personnel; blinding of outcome assessment)
for all included studies for consistency with the delirium prevention in hospitalised adults review.
We changed the outcome previously listed as ’unplanned hospitalisations’, to ’hospital admissions’ to better represent the data, which
included both planned and unplanned hospital admissions.
Previous review version (2014)
Following publication of the protocol, amendments were made to Measures of treatment effect and Data synthesis to incorporate the
analysis of adjusted data from cluster-randomised trials using generic inverse variance methods. A post hoc decision was made to include
the adverse outcome of falls in the ’Summary of findings’ tables. We planned participant-level subgroup
analyses for those with and without dementia, but we were unable to conduct these analyses because of limitations in reporting. We
planned sensitivity analyses for trials at low risk of methodological bias, but these were not possible because of the very small number
of included trials.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Institutionalization; ∗Long-Term Care; Delirium [chemically induced; ∗prevention & control]; Fluid Therapy; Frail Elderly; Medi-
cation Reconciliation; Randomized Controlled Trials as Topic
MeSH check words
Aged; Humans
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